Linked Life Data

10853668

Source:http://linkedlifedata.com/resource/pubmed/id/10853668

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2000-11-15
pubmed:databankReference
pubmed:abstractText
A series of indole and carbazole based inhibitors of factor Xa (FXa) has been investigated. The most potent compound inhibits FXa with a Ki of 0.2 nM and has 900- and 750-fold selectivity over thrombin and trypsin, respectively.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
957-61
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors.
pubmed:affiliation
Discovery Research, Berlex Biosciences, Richmond, CA 94804, USA. damian_arnaiz@berlex.com
pubmed:publicationType
Journal Article